BIOTIE THERAPIES CORP. STOCK EXCHANGE ANNOUNCEMENT
9 January 2007 at 4.15 p.m.
NOTIFICATION UNDER CHAPTER 2, SECTION 10 OF THE FINNISH SECURITIES
MARKET ACT REGARDING A CHANGE IN HOLDINGS
Biotie Therapies Corp. (the Company) has received the following
notifications under Chapter 2, Section 9 of the Finnish Securities
Market Act regarding a change in holdings:
As a result of 11,365,242 new shares being issued on 27 December
2007 by Biotie Therapies Corp., the aggregate holdings of Pequot
Healthcare Fund, L.P., Pequot Healthcare Offshore Fund, Inc.,
Premium Series PCC Limited Cell 32, Pequot Diversified Master
Fund, Ltd., Pequot Healthcare Institutional Fund, L.P. and Pequot
Healthcare Emerging Markets Fund, Ltd. (jointly, the Funds) have
decreased from 25.09% to 23.16% of the share capital and voting
rights in the Company, calculated on the basis of the number of
shares registered in the Finnish Trade Register. As a result of
the new shares being issued, no individual Fund has decreased its
holdings below or above 5% of the voting rights and share capital
of the company.
Shareholder Number of Proportion of
shares share capital
and voting
rights
Pequot Healthcare Fund, L.P. 7,213,845 8.06%
Pequot Healthcare Offshore Fund, Inc. 5,486,483 6.13%
Premium Series PCC Limited 32 Cell 998,490 1.12%
Pequot Diversified Master Fund, Ltd. 1,201,800 1.34%
Pequot Healthcare Institutional Fund, 1,337,806 1.49%
L.P
Pequot Healthcare Emerging Markets 4,500,000 5.03%
Fund, Ltd.
Turku, 9 January 2007
Timo Veromaa
President and CEO
For further information, please contact:
Timo Veromaa, President and CEO, Biotie Therapies Corp.
tel. +358 2 274 8901, e-mail: timo.veromaa@biotie.com
www.biotie.com
DISTRIBUTION The Helsinki Stock Exchange
Main Media
NOTIFICATION UNDER CHAPTER 2, SECTION 10 OF THE FINNISH SECURITIES MARKET ACT REGARDING A CHANGE IN
| Source: Biotie Therapies